D. Langat

Prospective International Study of Incidence and Predictors of Immune Reconstitution Inflammatory Syndrome and Death in People Living With Human Immunodeficiency Virus and Severe Lymphopenia

J. Ananworanich, B. Agan, I. Sereti, 2020 .

One Month of Rifapentine plus Isoniazid to Prevent HIV‐Related Tuberculosis

R. Chaisson, S. Swindells, C. Fletcher, 2019, The New England journal of medicine.

Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention.

R. Chaisson, S. Swindells, C. Fletcher, 2020, The Journal of antimicrobial chemotherapy.

As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial

Jeffrey N. Martin, Minhee Kang, D. Dittmer, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Isoniazid Adherence Reduces Mortality and Incident Tuberculosis at 96 Weeks Among Adults Initiating Antiretroviral Therapy With Advanced Human Immunodeficiency Virus in Multiple High-Burden Settings

U. Lalloo, V. Veloso, C. Kityo, 2022, Open forum infectious diseases.

Prospective international study of incidence and predictors of immune reconstitution inflammatory syndrome and death in people with HIV and severe lymphopenia.

J. Ananworanich, B. Agan, Jing Wang, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women

K. Dooley, G. Montepiedra, V. Rouzier, 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

One Month of Rifapentine plus Isoniazid to Prevent HIV‐Related Tuberculosis

R. Chaisson, S. Swindells, C. Fletcher, 2019, The New England journal of medicine.

Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)—report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials Group

D. Clifford, U. Lalloo, E. Ticona, 2023, PloS one.

Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings

O. Martínez-Maza, Jeannette Y Lee, T. Campbell, 2023, Journal of acquired immune deficiency syndromes.